BIO News and Press, Bio-Rad Laboratories Inc. Class A From 05/07/24

2024-05-07 17:22:33 ET More on Bio-Rad Labs Bio-Rad: A Lackluster Picks-And-Shovels Life Science Company With A Key Investment Kicker Bio-Rad Laboratories, Inc. (BIO) Q4 2023 Earnings Call Transcript Bio-Rad Labs Q1 2024 Earnings Preview Oncocyte stock rallie...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compare...

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...

2024-05-06 17:35:55 ET More on Bio-Rad Labs Bio-Rad: A Lackluster Picks-And-Shovels Life Science Company With A Key Investment Kicker Oncocyte stock rallies 90% post-market on Bio-Rad partnership Read the full article on Seeking Alpha For further details see:...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital M...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the ...

2024-04-23 06:58:24 ET More on Danaher Danaher: All In On Life Sciences, And Market Update Danaher Corporation (DHR) TD Cowen 44th Annual Health Care Conference (Transcript) Danaher: Better Positioned For The Future Danaher Non-GAAP EPS of $1.92 beats by $0.2...

2024-04-22 12:53:43 ET More on S&P 500 Index: Fed's Commercial Banking Report Shows Economic Headwinds, But Deposit Growth Bucks Trend S&P 500: Capitulation? Week Starting 22nd April (Technical Analysis) Powell Playing Games: 'Sell In May' Is Now 'Sell Before...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conf...

2024-04-14 01:23:10 ET Summary Bio-Rad is a "picks and shovels" company in the life sciences industry, but lacks standout growth, margins, or returns, and that has been largely true for more than two decades. Recent trends in the life sciences space have been challenging, driving,...